OncoDiag
PrivateLast Round
Follow-on
Feb 5, 2025
Total Funding Raised
$4.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
OncoDiag operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a Follow-on round in February 2025.
OncoDiag is a genomics company that develops non-invasive diagnostic tests for the early detection and monitoring of bladder, colorectal, and prostate cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OncoDiag Comparables
Compare OncoDiag with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VitaDX | 84% | |
| Nonagen Bioscience Corporation | 83% | |
| Nonacus | 80% |
For institutional investors. Book with your work email.
OncoDiag Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on | Feb 5, 2025 | ||||
| Series A | Mar 15, 2021 |
For institutional investors. Book with your work email.
OncoDiag Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Les Business Angels des Grandes Écoles | Seed |
| Normandie Participations | Series A |
| Paris Business Angels | Follow-on, Series A |
| Les Business Angels des Grandes Ecoles | Follow-on, Series A |
| Angels Santé | Follow-on, Seed, Series A |
| Normandie Participations | Follow-on, Series A |
| Bpifrance | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 85% MoM.
- Apr 17, 2026
Monthly visitors grew 70% MoM, reaching 1.5K.
For institutional investors. Book with your work email.
OncoDiag Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OncoDiag's valuation, stock price, and market status.
Is OncoDiag a public or private company?
OncoDiag is a private company.
What is the current stock price of OncoDiag?
OncoDiag is a private company, so its shares have no public market price. Caplight tracks OncoDiag's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OncoDiag worth (valuation)?
Valuation information for OncoDiag is not publicly available.
Can I buy OncoDiag stock?
OncoDiag shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OncoDiag's last funding round?
OncoDiag's most recent funding round was Follow-on on February 5, 2025.
Who are the main investors in OncoDiag?
Key investors in OncoDiag include Les Business Angels des Grandes Écoles, Normandie Participations, Paris Business Angels, Les Business Angels des Grandes Ecoles, Angels Santé.
Will OncoDiag IPO soon?
No public IPO plans have been announced for OncoDiag.
How can I track OncoDiag secondary market activity?
Caplight tracks bids, offers, and trades in OncoDiag's shares on secondary markets.